Medical device manufacturers selling in the US and internationally face overlapping regulatory requirements: FDA 21 CFR Part 820 (Quality System Regulation) and ISO 13485. The good news is these frameworks are approximately 90% aligned. The challenge is in the details — design controls, risk management (ISO 14971), and post-market surveillance requirements differ in subtle but critical ways. We build integrated QMS systems that satisfy both with a single set of documentation.
Regulatory Convergence
FDA has been harmonizing 21 CFR Part 820 with ISO 13485 for years, and the proposed Quality Management System Regulation would align US requirements even more closely with the international standard. For medical device manufacturers, this convergence means building one quality system that satisfies both frameworks is not just possible — it is the most efficient strategy.
The key is understanding where the frameworks align, where they differ, and which framework sets the more stringent requirement in each area. By designing your QMS to meet the higher bar in every case, you automatically satisfy both without maintaining parallel processes.
Design Controls Comparison
Design controls represent the most significant area of difference between FDA QSR and ISO 13485. FDA 21 CFR 820.30 prescribes specific design control activities including design input, design output, design review, design verification, design validation, design transfer, and design changes. ISO 13485 Clause 7.3 covers similar territory but with more flexibility in implementation.
FDA enforcement expectations add practical requirements beyond the written regulation. FDA expects full traceability from user needs through design inputs to design outputs through verification and validation. Your design history file must tell a complete, traceable story of how user needs were translated into a safe and effective device.
Building One System
Start with ISO 13485 as your quality management system framework because it provides comprehensive management system structure including management responsibility, resource management, product realization, and measurement and analysis. Layer in FDA-specific requirements at each process point where the QSR adds detail beyond ISO 13485.
Your quality policy references both regulatory frameworks. Your design control procedure satisfies FDA expectations, which automatically satisfies ISO 13485. Your complaint handling process meets FDA timelines for MDR reporting. Your CAPA process includes the root cause analysis rigor that FDA expects. One system, one set of procedures, two frameworks satisfied.
Audit Readiness
A unified QMS simplifies audit preparation whether you are facing an ISO registrar audit or an FDA inspection. The same system, the same records, the same evidence of compliance applies to both. The difference is in the auditor perspective — ISO auditors focus on system compliance while FDA inspectors focus on product safety and regulatory compliance.
Prepare your team to explain your quality system from both perspectives. When an ISO auditor asks about design controls, respond in ISO 13485 language. When an FDA inspector asks about design controls, respond in 21 CFR 820 language. The underlying system is the same — only the communication framework differs.
